Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A404YL | ISIN: US00773U2078 | Ticker-Symbol: AVU0
Frankfurt
05.06.25 | 08:15
2,120 Euro
-2,75 % -0,060
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ADVERUM BIOTECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
ADVERUM BIOTECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,1402,20011:48

Aktuelle News zur ADVERUM BIOTECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.05.Adverum Biotechnologies GAAP EPS of -$2.25 misses by $0.311
14.05.Adverum Biotechnologies, Inc. - 10-Q, Quarterly Report1
14.05.Adverum Biotechnologies, Inc. - 8-K, Current Report3
02.05.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)121REDWOOD CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement...
► Artikel lesen
24.04.Hedge Fund and Insider Trading News: Ken Griffin, Steve Cohen, Scott Bessent, Balyasny Asset Management, Bridgewater Associates, Starboard Value, Maverick Capital, Kodai Capital Management, Antara Capital, Adverum Biotechnologies Inc (ADVM), and More2
16.04.RBC cuts Adverum stock price target to $5 from $103
15.04.Adverum Biotechnologies GAAP EPS of -$1.96 misses by $0.601
15.04.Adverum Biotechnologies, Inc. - 8-K, Current Report1
ADVERUM BIOTECHNOLOGIES Aktie jetzt für 0€ handeln
15.04.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones109REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly...
► Artikel lesen
15.04.Adverum Biotechnologies, Inc. - 10-K, Annual Report1
04.04.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)125REDWOOD CITY, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted an inducement...
► Artikel lesen
31.03.Adverum Biotechnologies, Inc. - 8-K, Current Report2
04.03.Oppenheimer maintains Outperform on Adverum stock, $32 target1
03.03.Adverum launches phase 3 trial for wet AMD gene therapy3
03.03.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD201Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMDARTEMIS...
► Artikel lesen
28.02.Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)194REDWOOD CITY, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement...
► Artikel lesen
27.02.Adverum Biotechnologies, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
19.12.24Adverum Biotechnologies, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
06.12.24Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)185REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on December 4, 2024, the Compensation Committee of Adverum's Board of Directors...
► Artikel lesen
20.11.24Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)146REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on November 17, 2024, the Compensation Committee of Adverum's Board of Directors...
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1